True10 Electropolished Stainless Steel Tubing
High Purity Tubing for pharmaceutical, semiconductor, biotechnology, and other processes requiring finishes to 10 u-in Ra ID maximum. RathGibson's True10 tubing is manufactured to ASME BPE and ASTM A270 S2 standards, making it ideal for ultra high purity applications. By utilizing RathGibson's Micro-Weld technology and proprietary electropolishing process, ID surface anomalies are minimized, providing an ultra-smooth, corrosion resistant, chromium enriched surface where contaminants cannot hide. This electropolished tubing is processed and packaged in a certified ISO Class 5 Cleanroom (Fed 209E), a must for manufacturing tubing intended for use
in today's ultra purity environments. Sizes available are 1/2" (12.7 mm) to 6" (152.4 mm)
At Liquidyne, we prioritize our commitment to quality and consistency. In 2017 we achieved ISO 9001:2015 Quality Management System certification to ensure we can repeatedly deliver consistently high-quality products and solutions. Being an ISO 9001 facility, together with our USP Class VI Testing, ASME Bioprocessing Equipment (BPE), and EHEDG certification guarantee, we have the methodologies to assure quality. We will quickly and accurately rectify any issues if any of our products are ever in non-conformance.
"Thanks so much! What a quick turn around. It is a pleasure working with Liquidyne."
Process Development Manager
"I received the cart yesterday, thanks for the fast delivery! It feels sturdy. I sat on it. It does not bounce. It is also easy to clean and wipe or wash down."
Vice President, Analytical Development and Manufacturing
"Thanks again for reacting so quickly and meeting me halfway with the element. We will be able to get installed and have things keep moving overnight with the night crew. The little things like this are always greatly appreciated when working with Liquidyne."
“This pump cut our processing time from 3 days to 1 shift. I’m not giving this pump back. You will have to come and get it if you want it... and that won’t likely happen.”
VP Antibody Manufacturing